Immunomedics, Inc. (IMMU) Posts Q1 Loss of 10c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Foreign currency transaction gain: 2.46K
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Foreign currency transaction gain: 2.46K
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Immunomedics, Inc. (NASDAQ: IMMU) reported Q1 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.2 million.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Ship Finance (SFL) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
